The 5-Cog paradigm to improve detection of cognitive impairment and dementia: clinical trial protocol

Rachel Chalmer, Emmeline Ayers, Erica F. Weiss, Rubina Malik, Amy Ehrlich, Cuiling Wang, Jessica Zwerling, Asif Ansari, Katherine L. Possin, Joe Verghese

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Cognitive impairment related to dementia is under-diagnosed in primary care despite availability of numerous cognitive assessment tools; under-diagnosis is more prevalent for members of racial and ethnic minority groups. Clinical decision-support systems may improve rates of primary care providers responding to positive cognitive assessments with appropriate follow-up. The 5-Cog study is a randomized controlled trial in 1200 predominantly Black and Hispanic older adults from an urban underserved community who are presenting to primary care with cognitive concerns. The study will validate a novel 5-minute cognitive assessment coupled with an electronic medical record-embedded decision tree to overcome the barriers of current cognitive assessment paradigms in primary care and facilitate improved dementia care.

Original languageEnglish (US)
Pages (from-to)171-184
Number of pages14
JournalNeurodegenerative disease management
Volume12
Issue number4
DOIs
StatePublished - Aug 2022

Keywords

  • clinical trial protocol
  • cognitive assessment
  • cognitive impairment
  • cognitive screening
  • dementia
  • dissemination and implementation science
  • randomized controlled trial

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'The 5-Cog paradigm to improve detection of cognitive impairment and dementia: clinical trial protocol'. Together they form a unique fingerprint.

Cite this